For the quarter ending 2026-03-31, INBS has $14,862,792 in assets. $6,111,476 in debts. $6,862,204 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Assets held for sale | - | 0 | 66,020 | 327,500 |
| Cash and cash equivalents | 6,862,204 | 740,371 | 1,660,105 | 1,019,909 |
| Accounts receivable, net | 878,357 | 456,657 | 717,823 | 594,614 |
| Subscription receivable from shareholders, net | - | 9,402,105 | - | - |
| Other current assets | - | 480,133 | 488,182 | 826,976 |
| Inventories | 597,469 | 590,246 | 628,177 | 635,215 |
| Research and development tax incentive receivable | 568,600 | 505,172 | 924,062 | 734,408 |
| Prepaid expenses and other current assets | 843,090 | - | - | - |
| Total current assets | 9,749,720 | 12,174,684 | 4,484,369 | 4,138,622 |
| Property and equipment, net | 312,276 | 321,741 | 271,745 | 251,325 |
| Operating lease right-of-use assets | 1,801,622 | 1,887,178 | 1,808,892 | 69,520 |
| Intangibles, net | 2,999,174 | 3,269,439 | 3,473,303 | 3,790,319 |
| Total assets | 14,862,792 | 17,653,042 | 10,038,309 | 8,249,786 |
| Accounts payable and accrued expenses | 3,635,719 | 4,261,236 | 3,992,427 | 4,534,246 |
| Current portion of operating lease liabilities | 388,746 | 382,518 | 362,801 | 84,659 |
| Notes payable | - | 13,001 | 139,787 | 197,146 |
| Current employee benefit liabilities | 586,637 | 470,486 | 567,059 | 534,990 |
| Deferred grant income | - | - | - | 0 |
| Total current liabilities | 4,611,102 | 5,127,241 | 5,062,074 | 5,351,041 |
| Employee benefit liabilities, less current portion | 40,696 | 106,926 | 100,041 | 84,921 |
| Operating lease liabilities, less current portion | 1,459,678 | 1,529,064 | 1,449,265 | 0 |
| Total liabilities | 6,111,476 | 6,763,231 | 6,611,380 | 5,435,962 |
| Common stock, 0.01 par value, 100,000,000 shares authorized, 2,001,185 and 2,001,173 shares issued and outstanding, as of march 31, 2026, respectively 732,338 and 732,326 shares issued and outstanding, as of june 30, 2025, respectively | 20,012 | 12,384 | 90,985 | 73,230 |
| Treasury stock, at cost, 12 shares as of march 31, 2026 and june 30, 2025, respectively | 1 | 1 | 1 | 1 |
| Additional paid-in capital | 80,497,637 | 79,540,489 | 69,325,542 | 65,783,916 |
| Accumulated deficit | -71,056,373 | -68,193,661 | -65,516,071 | -62,533,065 |
| Accumulated other comprehensive loss | -499,710 | -266,079 | -279,228 | -327,944 |
| Total consolidated intelligent bio solutions inc. equity | 8,961,565 | 11,093,132 | 3,621,227 | 2,996,136 |
| Non-controlling interest | -210,249 | -203,321 | -194,298 | -182,312 |
| Total shareholders equity | 8,751,316 | 10,889,811 | 3,426,929 | 2,813,824 |
| Total liabilities and shareholders equity | 14,862,792 | 17,653,042 | 10,038,309 | 8,249,786 |
INTELLIGENT BIO SOLUTIONS INC. (INBS)
INTELLIGENT BIO SOLUTIONS INC. (INBS)